With roots in Germany, Carsten Thiel has studied at some of the most prestigious institutions including the Max Planck Institute. There, he focused him studies on a particular protein involved in the progression of normal, healthy cells into cancer-ridden ones. He entered the pharmaceutical field when he joined the firm Hoffman La-Roche. Working as the Communication and Production manager, Thiel built a positive reputation and was offered a job into another field. During his career, he has released many successful products such as Prolia and Vectibix.
Carsten Thiel’s roles often required him to be a leader to his team and provide an example for them to follow. His sense of ethics made this easier because he would have to choose the options better for patients and products that would fare well in the long run, if not initially. Doing the right thing by his patients gives Thiel a sense of pride to know that the work he has done is not going unappreciated. As a result, sales and revenue for the company increased, as well as customers’ trust and faith in it. See This Page for additional information.
During Thiel’s time working with Amgen, Carsten Thiel was responsible for the launch of a product which would treat bone loss and fractures in women. The system being used at the time did not take into consideration all he possible patients who could need it, but instead a select few who were registered into the system and showed an obvious need. Carsten Thiel altered the system to uncover not-so-obvious patients and they were now able to discuss details and obtain the treatment.
This product is now one of the leading in the field of osteoporosis, providing more patients than ever with the care they need and deserve. Thiel’s compassion leads him to strive for patient satisfaction with all age ranges.
An article from IdeaMensch entitled: “Carsten Thiel: Pharmaceutical & Biopharmaceutical Expert”, Thiel shared how he started his foray into the innovative realm of pharmaceuticals and further expressed his views about the “Golden Age of Biotechnology”.
Like him on https://www.facebook.com/carsten.thiel.58